products  axogen inc axgn home about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses news  events press releases axogen in the news events press kit products investors investor relations ir overview news  events news  events press releases axogen in the news ir calendar clinical conferences presentations email alerts company information corporate profile management team ir contacts faq financial information financial information financials financial results stock data stock data current quote charts historical data analyst coverage sec filings sec filings all sec filings annual reports quarterly reports section  filings proxy statements corporate governance corporate governance board of directors board committees governance docs contact the board careers contact for patients science of nerve repair about the nervous system peripheral nerve injuries pni pni map ways to diagnose pni how peripheral nerves repair nerve injuries and treatment options medical glossary resources find a nerve surgeon about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses products axogen provides solutions for your clinical needs avance® nerve graft is an offtheshelf processed human nerve allograft intended for the surgical repair of peripheral nerve discontinuities through a proprietary cleansing learn about avance® nerve graft view all products axoguard® nerve connector is the only porcine submucosa extracellular matrix “ecm” coaptation aid for tensionless repair of transected or severed peripheral nerves learn about axoguard® nerve connector view all products axoguard® nerve protector is the only  porcine submucosa extracellular ecm matrix surgical implant used to  protect injured nerves and to reinforce the nerve learn about axoguard® nerve protector view all products avive™ soft tissue membrane is a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissue layers  avive™ soft learn about avive™ soft tissue membrane view all products acroval™ neurosensory  motor testing system nsmts is a nerve function evaluation system designed to be used as a tool for surgeons and other allied health professionals in the learn about acroval™ nsmts view all products sensibility testing plays an important role in the evaluation of nerve function it assists the healthcare professionals in detecting changes in sensation assessing return of sensory function learn about axotouch™ twopoint discriminator view all products patient stories jeffrey’s story matthews story shirleys story how to order orders may be placed by phone fax or email through axogen customer care phoneaxogen  fax autofax emailcustomercareaxogeninccom latest news july   axogen inc discloses terms of recent equity award july   axogen inc to report second quarter  financial results and host conference call on wednesday august   july   axogen inc appoints jon gingrich chief commercial officer june   axogen inc to present at the jmp securities life sciences conference may   axogen inc to present at the jefferies global healthcare conference contact information we would love to hear from you phoneaxogen  fax autofax emailcustomercareaxogeninccom axgn price  change undefined  high low volume updated search receive axogen emails sign up to receive updates and news from axogen first name last name email address avance® nerve graft  axogen inc axgn home about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses news  events press releases axogen in the news events press kit products investors investor relations ir overview news  events news  events press releases axogen in the news ir calendar clinical conferences presentations email alerts company information corporate profile management team ir contacts faq financial information financial information financials financial results stock data stock data current quote charts historical data analyst coverage sec filings sec filings all sec filings annual reports quarterly reports section  filings proxy statements corporate governance corporate governance board of directors board committees governance docs contact the board careers contact for patients science of nerve repair about the nervous system peripheral nerve injuries pni pni map ways to diagnose pni how peripheral nerves repair nerve injuries and treatment options medical glossary resources find a nerve surgeon about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses avance® nerve graft products avance® nerve graft axoguard® nerve connector axoguard® nerve protector avive™ soft tissue membrane acroval™ nsmts axotouch™ twopoint discriminator science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses avance® nerve graft is an offtheshelf processed human nerve allograft intended for the surgical repair of peripheral nerve discontinuities through a proprietary cleansing process for recovered human peripheral nerve tissue the graft preserves the essential inherent structure of the ecm while cleansing away cellular and noncellular debris avance® nerve graft provides the following key advantages three dimensional scaffold for bridging a nerve gap decellularized and cleansed extracellular matrixthat remodels into patient’s own tissue no donor nerve surgery therefore no comorbidities associated with an additional surgical site available in a variety of lengths and diameters to meet a range of gap lengths and anatomical needs supplied sterile with three years shelf life kept frozen at or below º cf   nerve matters axogen strives to broaden the research and knowledge base of peripheral nerve injury and repair by identifying what factors “matter” in nerve repair  the links below provide information about how processing and structure of nerve repair options may affect outcomes avance® nerve graft processing matters avance® nerve graft structure matters   regulatory classification avance® nerve graft is a human tissue for transplantation avance® nerve graft is processed and distributed in accordance with us fda requirements for human cellular and tissuebased products hctp under  cfr part  regulations us state regulations and the guidelines of the american association of tissue banks aatb additionally international regulations are followed as appropriate this graft is to be dispensed only by or on the order of a licensed physician indications for use avance® nerve graft is processed nerve allograft human intended for the surgical repair of peripheral nerve discontinuities to support regeneration across the defect contraindications avance® nerve graft is contraindicated for use in any patient in whom soft tissue implants are contraindicated this includes any pathology that would limit the blood supply and compromise healing or evidence of a current infection warnings careful donor screening laboratory testing tissue processing and gamma irradiation have been utilized to minimize the risk of transmission of relevant communicable diseases to the patient as with any processed human donor tissue avance® cannot be guaranteed to be free of all pathogens do not reuse or resterilize avance® nerve graft and do not refreeze product if thawed   hover over page elements to highlight them then click to create an annotation   hover over page elements to highlight them then click to create an annotation share linkedin twitter patient stories jeffrey’s story matthews story shirleys story how to order orders may be placed by phone fax or email through axogen customer care phoneaxogen  fax autofax emailcustomercareaxogeninccom latest news july   axogen inc discloses terms of recent equity award july   axogen inc to report second quarter  financial results and host conference call on wednesday august   july   axogen inc appoints jon gingrich chief commercial officer june   axogen inc to present at the jmp securities life sciences conference may   axogen inc to present at the jefferies global healthcare conference contact information we would love to hear from you phoneaxogen  fax autofax emailcustomercareaxogeninccom axgn price  change undefined  high low volume updated search receive axogen emails sign up to receive updates and news from axogen first name last name email address axogen inc axgn home about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses news  events press releases axogen in the news events press kit products investors investor relations ir overview news  events news  events press releases axogen in the news ir calendar clinical conferences presentations email alerts company information corporate profile management team ir contacts faq financial information financial information financials financial results stock data stock data current quote charts historical data analyst coverage sec filings sec filings all sec filings annual reports quarterly reports section  filings proxy statements corporate governance corporate governance board of directors board committees governance docs contact the board careers contact for patients science of nerve repair about the nervous system peripheral nerve injuries pni pni map ways to diagnose pni how peripheral nerves repair nerve injuries and treatment options medical glossary resources find a nerve surgeon about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses it’s time to rethink nerve repair™ welcome to axogen nasdaq axgn a leading medical technology company dedicated to peripheral nerve repair axogen introduces click here for details learn about avance nerve graft axogens find a nerve surgeon locator tool click here to find a nerve surgeon jeffrey’s story read this patient story shirleys story read this patient story axogen q  earnings call may   pm et listen to the q  earnings call tollfree at   or listen to the conference call live at axogenincequisolvewebcastcomq webcast th annual roth conference march   listen to a replay of the march  roth conference webcast canaccord genuity musculoskeletal conference march   listen to a replay of the march  canaccord conference webcast oppenheimer th annual healthcare conference march   listen to a replay of the march  oppenheimer conference webcast  annual axogen shareholder’s meeting may   pm et renaissance orlando airport hotelorlando fl virtual meeting connecting nerves connecting lives axogen inc seeks to provide surgeons with solutions to repair and protect peripheral nerves as well as provide solutions to measure and monitor nerve function the company has created and licensed a unique combination of patented technologies and has a rich pipeline of new products to change the standard of care for patients with peripheral nerve injuries read about axogen press releases axogen inc discloses terms of recent equity award july   axogen inc to report second quarter  financial results and host conference call on wednesday august   july   news  press resources all news press kit media resources press kit news  events press releases axogen inc discloses terms of recent equity award published by axogen july   axogen inc discloses terms of recent equity award read more press releases axogen inc to report second quarter  financial results and host conference call on wednesday august   published by axogen july   axogen inc to report second quarter  financial results and host conference call on wednesday august   read more press releases axogen inc appoints jon gingrich chief commercial officer published by axogen july   axogen inc appoints jon gingrich chief commercial officer read more avance® nerve graft watch the animation  surgical repair of a peripheral nerve gap with avance® nerve graft axgn price  change undefined  high low volume updated search receive axogen emails sign up to receive updates and news from axogen first name last name email address corporate profile  axogen inc axgn home about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses news  events press releases axogen in the news events press kit products investors investor relations ir overview news  events news  events press releases axogen in the news ir calendar clinical conferences presentations email alerts company information corporate profile management team ir contacts faq financial information financial information financials financial results stock data stock data current quote charts historical data analyst coverage sec filings sec filings all sec filings annual reports quarterly reports section  filings proxy statements corporate governance corporate governance board of directors board committees governance docs contact the board careers contact for patients science of nerve repair about the nervous system peripheral nerve injuries pni pni map ways to diagnose pni how peripheral nerves repair nerve injuries and treatment options medical glossary resources find a nerve surgeon about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses corporate profile email alerts be the first to receive the latest news from axogen subscribe to alerts corporate profile it’s time to rethink nerve repair™ axogen nasdaq axgn is a leading medical technology company dedicated to peripheral nerve repair the company has created and licensed a unique combination of patented nerve repair technologies to change the standard of care for patients with peripheral nerve injuries axogens portfolio of regenerative medicine products is available in the united states canada and several other countries and includes avance® nerve graft an offtheshelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with an additional surgical site axoguard® nerve connector a porcine submucosa extracellular matrix ecm coaptation aid for tensionless repair of severed nerves and axoguard® nerve protector a porcine submucosa ecm product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments company overview only company focused on peripheral nerve repair solutions addressing a b current market opportunity comprehensive product portfolio addresses all surgical peripheral nerve reconstruction needs pioneering sales and market strategy solid execution plan poised for strong growth  gross margins barriers to competitive entry  growing body of clinical data long term expansion potential beyond current market our market axogen is a pioneer in the regenerative medicine market with a portfolio of products for peripheral nerve reconstruction our technologies provide an option for surgeons to reconstruct injured nerves without the comorbidities associated with a secondary surgical site further they offer surgeons an opportunity to protect compressed nerves or reconstruct injured nerves our technologies are used by several surgical specialties and in peripheral nerves throughout the body based on research and analysis the us market for the repair of transected peripheral nerves in the extremities exceeds  billion axogen is actively targeting this market and expanding focus in ous markets our current focus upper extremity lower extremity carpal tunnel revision oral and maxillofacial axogens future expansion opportunities include facial reconstruction podiatry breast reconstruction prostatectomy and pain management market research reports analysis by an independent third party research group concluded that the us market for the repair of transected peripheral nerves in the extremities alone exceeds  billion for further information on the analysis click here  our products axogens proprietary products and technologies are designed to overcome fundamental challenges in nerve reconstruction and offer offtheshelf solutions to surgeons for a wide variety of peripheral nerve injuries avance® nerve graft is a processed nerve allograft for bridging nerve discontinuities avance® nerve graft follows the guiding principle that the human body created the optimal nerve structure the human nerve allograft is decellularized and processed resulting in a surgical implant with the natural structural pathways to guide axon regeneration avance® nerve graft is provided in a variety of diameters up to mm and a variety of lengths up to  mm provides the flexibility to be used across joints and handles similarly to an autograft nerve without the comorbidities associated with an additional surgical site axoguard® nerve protector is a minimally processed intact extracellular matrix derived from porcine small intestine submucosa sis designed to wrap and protect injured peripheral nerves axoguard® nerve protector can reinforce a coaptation site wrap a partially severed or compressed nerve and isolate tissue axoguard® nerve protector can be used to wrap injured nerves up to  mm in length easily conforms to and wraps the injured nerve and minimizes the potential for soft tissue attachments and nerve entrapment by physically isolating the nerve further it is strong flexible and easy to suture axoguard® nerve connector is a minimally processed extracellular matrix derived from porcine small intestine submucosa sis designed as a coaptation aid for tensionless repair of transected or severed peripheral nerves axoguard® nerve connector can be used to bridge gaps up to  mm in length and alleviates tension at the repair site further it reduces the number of required sutures vs direct repair and the potential for fascicular mismatch axoguard® nerve connector is strong and flexible easy to suture and semitranslucent which allows visualization of the underlying nerve our clinical research axogen invests in and supports clinical studies and programs to further the understanding and outcomes of peripheral nerve repair a multicenter retrospective study of avance® nerve graft utilization evaluations and outcomes in peripheral nerve injury repair ranger® the ranger® study the avance® nerve graft registry has completed the first data milestone and continues to enroll additional cases a multicenter prospective randomized comparative study of hollow nerve conduit and avance® nerve graft evaluation recovery outcomes of the nerve repair in the hand change the change study is a pilot comparative study enrollment is now completed a multicenter prospective randomized subject and evaluator blinded comparative study of nerve cuffs and avance® nerve graft evaluating recovery outcomes for the repair of nerve discontinuities recon the primary objective of this study is to evaluate the difference in functional recovery outcome between the study groups cavernous nerve reconstruction using avance® nerve graft in subjects who undergo robotic assisted prostatectomy for treatment of prostate cancer this study is being conducted to assess the technical feasibility of robotic assisted implantation of avance® nerve graft and the long term outcomes for continence and potency in men undergoing radical prostatectomy enrollment is now completed our pipeline axogen will continue to work with leading researchers in an effort to further translate research into products that improve the standard of care for patients with peripheral nerve injuries we believe this approach provides a path to continue on the leading edge in our field and to increase our overall potential for success and growth axogen is engaged in a major initiative to build and further expand sales and marketing capabilities and to increase acceptance and clinical adoption from the medical community regulatory information axogens products are subject to international federal state and local regulations as healthcare products axogen meets the regulations for human tissue products and medical devices as required by the appropriate international and domestic regulatory agencies ie fda additionally axogen is an accredited tissue bank with the american association of tissue banks aatb and axogen is an iso  registered company axoguard® nerve protector and axoguard® nerve connector  fda k clearance avance® nerve graft  the axogen quality system meets the requirements set forth under  cfr §  for human cells tissues and cellular and tissuebased products including good tissue practices gtp  november  the us fda has issued an enforcement discretion letter allowing continued sales of avance® nerve graft under the controls applicable to a hctp pursuant to section  of the public health service act and  cfr part  of fdas regulations in accordance with a transition plan with the fda in which axogen transitions to compliance with the section ab of the federal food drug and cosmetic act the fdc act the current good manufacturing practice regulations in  cfr §  and  and the applicable regulations and standards in  cfr §  axogen conducts a phase  clinical trial to demonstrate safety purity and potency of the avance® nerve graft and axogen performs a phase  clinical study and axogen continues to comply with the regulations and standard for  cfr §  from time to time in reports filed with the securities and exchange commission in press releases and in other communications to shareholders or the investment community such as information contained in this website the company may provide forwardlooking statements concerning possible or anticipated future results of operations or business developments these statements are based on management’s current expectations or predictions of future conditions events or results based on various assumptions and management’s estimates of trends and economic factors in the markets in which we are active as well as our business plans words such as “expects” “anticipates” “intends” “plans” “believes” “seeks” “estimates” “projects” “forecasts” “may” “should” variations of such words and similar expressions are intended to identify such forwardlooking statements the forwardlooking statements may include without limitation statements regarding product development product potential regulatory environment sales and marketing strategies liquidity capital resources or operating performance the forwardlooking statements are subject to risks and uncertainties which may cause results to differ materially from those set forth in the statements forwardlooking statements in company communications should be evaluated together with the many uncertainties that affect the company’s business and its market particularly those discussed in the risk factors and cautionary statements in the company’s filings with the securities and exchange commission forwardlooking statements are not guarantees of future performance and actual results may differ materially from those projected the forwardlooking statements are representative only as of the date they are made and the company assumes no responsibility to update any forwardlooking statements whether as a result of new information future events or otherwise except as required by law ir contacts investor relations axogen inc  progress blvd suite  alachua fl  investorrelationsaxogeninccom transfer agent wells fargo shareowner services po box  st paul mn  t  email alerts be the first to receive the latest news and financial information subscribe quick links corporate presentation fact sheet email alerts ir contacts rss news feed axogen inc competitors and products in the medical equipment and supplies directory  medical equipment and supplies directoryaxogen incaxogen inc rating   write a review  progress blvd suite alachua fl about axogen incaxogen nasdaq axgn a leading medical technology company dedicated to peripheral nerve repairaxogen inc seeks to provide surgeons with solutions to repair and protect peripheral nerves as well as provide solutions to measure and monitor nerve function the company has created and licensed a unique combination of patented technologies and has a rich pipeline of new products to change the standard of care for patients with peripheral nerve injuriescompetitors of axogen incdealmed medical supplies llcdealmed is a leader in medical supplies distribution we provide medical supplies medical equipment drugs vaccines and specialty medical products and services our mission is simple we make it our business to understand how the products we sell impact patients’ lives everyday at dealmed read more send an email email sent  products write a reviewjohnson  johnsoncaring for the world one person at a time inspires and unites the people of johnson  johnson we embrace innovation—bringing ideas products and services to life to advance the health and wellbeing of people around the world we believe in collaboration and that has led to breakthrough read more send an email email sent  products write a reviewtetra medical supply corpestablished in  in chicago il and certified as a woman owned business since  tetra medical supply corp manufactures and distributes orthopedic soft goods hotcold therapy and a complete line of general wound care products including one of the most diversified selection of bandages write a review×rate and review axogen inc click on a star to rate this companyrating is requiredyour associationcustomerpartnersupplierother name title company post anonymouslyyour comments when writing a review please adhere to the review guidelines thanks for submitting your review of axogen inc well email you as soon as its published typically within  hours we really value your contributions and so does our community of business professionals they count on honest reviews like yoursthanks for submitting your review of axogen incwell email you as soon as its published typically within  hourswe really value your contributions and so does our community of business professionals they count on honest reviews like yoursclose×rate and review dealmed medical supplies llc click on a star to rate this companyrating is requiredyour associationcustomerpartnersupplierother name title company post anonymouslyyour comments when writing a review please adhere to the review guidelines thanks for submitting your review of dealmed medical supplies llc well email you as soon as its published typically within  hours we really value your contributions and so does our community of business professionals they count on honest reviews like yoursthanks for submitting your review of dealmed medical supplies llcwell email you as soon as its published typically within  hourswe really value your contributions and so does our community of business professionals they count on honest reviews like yoursclose×contact dealmed medical supplies llc your name email address your job functionadministrationceopresident ownercfocioctoconsultantcustomer serviceengineerprogrammerfacilitiesoperationsfinance managerfinance staffgeneral managerhuman resourcesis it staffisit managementmarketing managermarketing staffotherpartnerprincipalpurchasing managersales devsales dev managervpsenior manager your company subject line message i saw your company in the medical equipment and supplies directory and would like to have someone contact me information requestedclose×rate and review johnson  johnson click on a star to rate this companyrating is requiredyour associationcustomerpartnersupplierother name title company post anonymouslyyour comments when writing a review please adhere to the review guidelines thanks for submitting your review of johnson  johnson well email you as soon as its published typically within  hours we really value your contributions and so does our community of business professionals they count on honest reviews like yoursthanks for submitting your review of johnson  johnsonwell email you as soon as its published typically within  hourswe really value your contributions and so does our community of business professionals they count on honest reviews like yoursclose×contact johnson  johnson your name email address your job functionadministrationceopresident ownercfocioctoconsultantcustomer serviceengineerprogrammerfacilitiesoperationsfinance managerfinance staffgeneral managerhuman resourcesis it staffisit managementmarketing managermarketing staffotherpartnerprincipalpurchasing managersales devsales dev managervpsenior manager your company subject line message i saw your company in the medical equipment and supplies directory and would like to have someone contact me information requestedclose×rate and review tetra medical supply corp click on a star to rate this companyrating is requiredyour associationcustomerpartnersupplierother name title company post anonymouslyyour comments when writing a review please adhere to the review guidelines thanks for submitting your review of tetra medical supply corp well email you as soon as its published typically within  hours we really value your contributions and so does our community of business professionals they count on honest reviews like yoursthanks for submitting your review of tetra medical supply corpwell email you as soon as its published typically within  hourswe really value your contributions and so does our community of business professionals they count on honest reviews like yoursclose×sign up for full directory site access or loginlogin or sign upforgot passwordlinkedin useryou can use your linkedin account to login to medical equipment and supplies directory login with linkedinemail addresspasswordinvalid username or password    forgot passwordprivacy policy  terms of uselinkedin useryou can use your linkedin account to sign up for medical equipment and supplies directory sign up with linkedinnameemail addressjob functionadministrationceopresident ownercfocioctoconsultantcustomer serviceengineerprogrammerfacilitiesoperationsfinance managerfinance staffgeneral managerhuman resourcesis it staffisit managementmarketing managermarketing staffotherpartnerprincipalpurchasing managersales devsales dev managervpsenior manager company namepasswordaccount already exists please login with correct username and passwordprivacy policy  terms of useforgot your password enter the email address on your account we will email you information to reset your password loginemail address axogen inc assh home contact us login menu curriculum topics hand and wrist elbow and forearm shoulder and arm diseases and disorders congenital and pediatric problems nerve general principles practice management government affairs professional services and personal development product categories trauma fractures bone reconstruction sports arthroscopy soft tissue reconstruction arthritis arthroplasty joint reconstruction cartilage biologics synthetics imaging technology tools service providers publishers vendor list news  events hande exhibitors  partners annual meeting exhibits industry support recognition annual meeting exhibitor badges new product showcase corporate product store purchase mailing labels general mailing list purchase member insights survey standalone course opportunities partnership grants  special programs corporate advisory council commercial support committee unrestricted educational grant branding  advertising industry forums product workshops web banner advertising email banner advertising yearround brochure top assh  afsh initiatives annual meeting sponsorship opportunities annual meeting advertising opportunities american foundation for surgery of the hand assh yearround visibility opportunities news  resources important dates  deadlines exhibitor resources assh corporate policies guide advertising sales kit company profile video guidelines website banner artwork guidelines and screenshots menu curriculum topics hand and wrist elbow and forearm shoulder and arm diseases and disorders congenital and pediatric problems nerve general principles practice management government affairs professional services and personal development product categories trauma fractures bone reconstruction sports arthroscopy soft tissue reconstruction arthritis arthroplasty joint reconstruction cartilage biologics synthetics imaging technology tools service providers publishers vendor list news  events hande exhibitors  partners annual meeting exhibits industry support recognition annual meeting exhibitor badges new product showcase corporate product store purchase mailing labels general mailing list purchase member insights survey standalone course opportunities partnership grants  special programs corporate advisory council commercial support committee unrestricted educational grant branding  advertising industry forums product workshops web banner advertising email banner advertising yearround brochure top assh  afsh initiatives annual meeting sponsorship opportunities annual meeting advertising opportunities american foundation for surgery of the hand assh yearround visibility opportunities news  resources important dates  deadlines exhibitor resources assh corporate policies guide advertising sales kit company profile video guidelines website banner artwork guidelines and screenshots menu menu curriculum topics hand and wrist elbow and forearm shoulder and arm diseases and disorders congenital and pediatric problems nerve general principles practice management government affairs professional services and personal development product categories trauma fractures bone reconstruction sports arthroscopy soft tissue reconstruction arthritis arthroplasty joint reconstruction cartilage biologics synthetics imaging technology tools service providers publishers vendor list news  events hande exhibitors  partners annual meeting exhibits industry support recognition annual meeting exhibitor badges new product showcase corporate product store purchase mailing labels general mailing list purchase member insights survey standalone course opportunities partnership grants  special programs corporate advisory council commercial support committee unrestricted educational grant branding  advertising industry forums product workshops web banner advertising email banner advertising yearround brochure top assh  afsh initiatives annual meeting sponsorship opportunities annual meeting advertising opportunities american foundation for surgery of the hand assh yearround visibility opportunities news  resources important dates  deadlines exhibitor resources assh corporate policies guide advertising sales kit company profile video guidelines website banner artwork guidelines and screenshots homevendor listvendor information axogen inc twittercomaxogen wwwlinkedincomcompanyaxogen  progress boulevard suite  alachua fl  ph   fax customercareaxogeninccom wwwaxogeninccom axogen offers innovative solutions for peripheral nerve repair including avance nerve graft an allograft tissue for bridging nerve discontinuities axoguard nerve protector a wrap for protecting peripheral nerves axoguard nerve connector a nerve find a sales rep find products product categories biologicssynthetics curriculum topics nerve events we dont have anything to display here related videos american societyfor surgery of the hand  w washington blvdchicago il  phone  email infoasshorg hande member resources courses annual meeting about assh my library patient resources afsh assh home contact us my account login cme mission statement and disclaimer policies and technical requirements exhibitors  partners media   american society for surgery of the hand axgn key statistics  axogen inc financial ratios  marketwatch bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close axogen inc nasdaq axgn go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus axogen inc after hours  quotes are delayed by  min jul    pm axgn quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description axogen inc offers surgical solutions for peripheral nerve injuries it focuses specifically on the science development and commercialization of technologies for peripheral nerve regeneration and repair its products include avance nerve graft axoguard nerve protector and axoguard nerve connector axogen inc offers surgical solutions for peripheral nerve injuries it focuses specifically on the science development and commercialization of technologies for peripheral nerve regeneration and repair its products include avance nerve graft axoguard nerve protector and axoguard nerve connector the companys portfolio of products is available in the united states canada the united kingdom and several other european and international countries axogen was founded in  and is headquartered in alachua fl valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  longterm debt to equity  longterm debt to total capital  officers and executives name age officer since title ms karen l zaderej   president chief executive officer  director mr mike donovan   vice presidentoperations mr peter j mariani   chief financial officer  headinvestor relations dr ivica ducic   medical directorclinical  translational sciences mr jon s gingrich   chief commercial officer insider actions – purchase – sale  – number of transactions  date name shares transaction value  mark stephen gold director    derivativenonderivative trans at  per share   mark stephen gold director    derivativenonderivative trans at  per share   mike donovan vp operations    derivativenonderivative trans at  per share   mike donovan vp operations    derivativenonderivative trans at  per share   erick wayne devinney vp clinicaltranslational sc    derivativenonderivative trans at  per share   erick wayne devinney vp clinicaltranslational sc    derivativenonderivative trans at  per share   gregory g freitag general counsel  svp bd director    derivativenonderivative trans at  per share   karen l zaderej ceo director    award at  per share   karen l zaderej ceo director    acquisition at  per share   john p engels vp    acquisition at  per share   amy a mcbridewendell director    acquisition at  per share   peter j mariani chief financial officer    acquisition at  per share   kevin leach vice president marketing    acquisition at  per share   mark stephen gold director    derivativenonderivative trans at  per share   de novo ventures director    disposition at  per share   de novo ventures director    disposition at  per share   deerfield management company lp    disposition at  per share  newslatestcompanyusaxgn marketwatch news on axgn no news currently available for axgn newsnonmarketwatchcompanyusaxgn other news on axgn axogen appoints jon gingrich as cco  am july    seeking alpha axogen axgn presents at jmp securities life sciences conference   slideshow  pm june    seeking alpha axogen axgn presents at jefferies  global healthcare conference  slideshow  pm june    seeking alpha axogens axgn ceo karen zaderej hosts  annual shareholders meeting transcript  pm may    seeking alpha axogen axgn shows strength stock adds  in session  am may    zackscom commentary on opaleye management positions part i  am may    seeking alpha axogens axgn ceo karen zaderej on q  results  earnings call transcript  pm may    seeking alpha buy skyworks solutions after analyst downgrade  cramers lightning round   am april    seeking alpha k axogen inc  pm march    edgar online  edg  q k axogens axgn ceo karen zaderej on q  results  earnings call transcript  pm feb    seeking alpha zackscom featured highlights axogen mag silver triumph bancorp ucp and yelp  am jan    zackscom how to uncover institutional buying  pm jan    zackscom axogen preannounces q and fy revenue  am jan    seeking alpha biggest movers in manufacturing stocks now – myov elgx bmra ivac  pm dec    investorplacecom  health care equipment  supplies stocks to buy now  am nov    investorplacecom biggest movers in manufacturing stocks now – immr cara cbm ctrl  am nov    investorplacecom axogens axgn ceo karen zaderej on q  results  earnings call transcript  pm nov    seeking alpha q axogen inc  pm nov    edgar online  edg  q k insiderinsightscom daily round up  fstr alny axgn  am oct    seeking alpha the long case for axogen  am oct    seeking alpha loading more headlines at a glance axogen inc  progress boulevard suite  alachua florida  phone   industry medical equipmentsupplies sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for axgn newspressreleasecompanyusaxgn press releases on axgn axogen inc discloses terms of recent equity award  pm july    globenewswire axogen inc to report second quarter  financial results and host conference call on wednesday august    am july    globenewswire axogen inc appoints jon gingrich chief commercial officer  am july    globenewswire axogen inc to present at the jmp securities life sciences conference  am june    globenewswire axogen inc to present at the jefferies global healthcare conference  am may    globenewswire axogen inc reports  first quarter financial results  pm may    globenewswire investor network axogen inc to host earnings call  am may    accesswire axogen inc to report first quarter  financial results and host conference call on thursday may    am april    globenewswire axogen inc announces  annual shareholders meeting  am april    globenewswire axogen inc to present at the oppenheimer th annual healthcare conference  am march    globenewswire axogen inc to present at upcoming investor conferences  am march    globenewswire axogen inc reports  fourth quarter and full year financial results  pm feb    globenewswire axogen inc to report fourth quarter and  full year financial results and host conference call on wednesday february    am feb    globenewswire axogen inc preannounces estimated fourth quarter and full year  revenue  am jan    globenewswire axogen appoints ivica ducic medical director  pm jan    globenewswire axogen to participate at aahs aspn asrm joint  annual meeting  am jan    globenewswire axogen inc announces avancer nerve graft recipient to be honored on the donate life tournament of roses parade float  am dec    globenewswire valeritas elects joe mandato phd experienced medical device executive and investor to board of directors  am nov    globenewswire axogen inc announces commercial release and first clinical implant of avivetm soft tissue membrane  am nov    globenewswire axogen inc to present at the th annual piper jaffray healthcare conference  am nov    globenewswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest acocacola tops earnings estimates after cost cuts aa money manager struggles with the social pressure for ‘more house’ aatt shares gain  in premarket after company surprises analyst with q wireless results aboeing raises guidance after profit beat abiogen shares surge  after upgrade to buy at goldman sachs amarkel to acquire stane national cos in  million cash deal achipotle says sick staffer spread norovirus causing  billion market cap loss arbb bancorp prices ipo at  a share anvidias stock climbs  in premarket trade aamds stock soars toward month high as analysts boost price targets after upbeat results acities to move to if you want to work in tech — not including san francisco abiogen shares surge  after goldman sachs upgrade abiogen upgraded to buy at goldman sachs on alzheimers drug underleveraged balance sheet athe allure of ‘damaged’ stocks as tech mania goes wild aall the signs silicon valley isn’t nearly as awesome as it thinks it is aupdate six flags shares dip  premarket after company misses profit revenue estimates apenske automotive raises quarterly dividend to  cents from  cents apenske automotive raises quarterly dividend to  cents vs  cents aus steel shares jump  premarket after earnings beat jp morgan rates stock overweight a‘stealth’ trump factors are lifting stocks these strategists say loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  faq  axogen inc axgn home about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses news  events press releases axogen in the news events press kit products investors investor relations ir overview news  events news  events press releases axogen in the news ir calendar clinical conferences presentations email alerts company information corporate profile management team ir contacts faq financial information financial information financials financial results stock data stock data current quote charts historical data analyst coverage sec filings sec filings all sec filings annual reports quarterly reports section  filings proxy statements corporate governance corporate governance board of directors board committees governance docs contact the board careers contact for patients science of nerve repair about the nervous system peripheral nerve injuries pni pni map ways to diagnose pni how peripheral nerves repair nerve injuries and treatment options medical glossary resources find a nerve surgeon about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses faq email alerts be the first to receive the latest news from axogen subscribe to alerts faq who is axogenaxogen inc is a regenerative medicine company focused on the development and commercialization of technologies for peripheral nerve reconstruction and regeneration the company has created and licensed a unique combination of patented technologies and offers a full portfolio of nerve repair and protection solutions for patients with peripheral nerve injurieswhat products does axogen offeraxogens products offer a full suite of surgical nerve reconstruction solutions including avance® nerve graft the only commercially available allograft nerve for bridging severed nerves without the comorbidities associated with a second surgical site axoguard® nerve connector a porcine submucosa ecm coaptation aid for tensionless repair of severed nerves and axoguard® nerve protector a porcine submucosa ecm product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachmentshow does axogen plan to maintain a competitive advantage in the peripheral nerve graft marketaxogen provides a patent protected product suite that addresses the surgical peripheral nerve continuum avance® nerve graft is a product used in nerve reconstruction where the gap between the nerve ends is typically greater than mm axogen developed avance® nerve graft by following the guiding principle that the human body created the optimal nerve structure processed from recovered human peripheral nerve tissue avance® nerve graft provides the natural nerve structure of an autograft nerve but with the ease and availability of an offtheshelf product axoguard® nerve protector minimizes the potential for soft tissue attachments and nerve entrapment by physically isolating the nerve during the healing process axoguard® nerve connector is for gaps between the nerve ends up to mm and provides a coaptation aid for the reconstruction both axoguard® nerve protector and axoguard® nerve connector provide the unique features of pliability suturability and translucence for visualization of the underlying nerve while allowing the patients own cells to incorporate into the extracellular matrix to remodel and form a tissue similar to the nerve epineurium through rd licensing or acquisition axogen will also continue to expand its product offering with products that bring the science of nerve repair to lifewhat is axogen incs stock symbolour stock is traded on the nasdaq under the symbol axgncan i buy stock directly from axogen incno you will need to contact a licensed stock broker or use an online trading accounthow can i buy stock in axogen incthrough a licensed stock broker or by using an online trading accounthow do i change the address on my shareholder accountthrough your brokerage account or by contacting our transfer agentwhere is axogen inc located progress blvd suite  alachua fl when is axogen incs fiscal year enddecember stwho is axogen incs transfer agentwells fargo shareowner services po box  st paul mn  t  wwwwellsfargocomcomshareownerserviceswho are axogen incs independent auditorslurie besikof lapidus  company llp  wayzata boulevard minneapolis mn  t who is axogen incs outside legal counseldla piper llp us one liberty place  market street suite  philadelphia pa does axogen pay a dividend and when will it be paidaxogen does not pay a dividend at this time future dividends will be determined by the board of directorshow do i get a copy of the companys financial statements such as an annual report sec filingsannual reports sec filings and financial statements are available for viewing on this website and can also be downloaded or printed to sign up to be notified when the annual report or latest sec filing is available please visit the email alerts section of the investors pagehow do i contact axogen investor relationsinvestor relationsaxogen inc progress blvdsuite alachua fl email investorrelationsaxogeninccom customer caretoll free us axogen  direct dial  fax  fax ir contacts investor relations axogen inc  progress blvd suite  alachua fl  investorrelationsaxogeninccom transfer agent wells fargo shareowner services po box  st paul mn  t  email alerts be the first to receive the latest news and financial information subscribe quick links corporate presentation fact sheet email alerts ir contacts rss news feed axogen inc axgn home about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses news  events press releases axogen in the news events press kit products investors investor relations ir overview news  events news  events press releases axogen in the news ir calendar clinical conferences presentations email alerts company information corporate profile management team ir contacts faq financial information financial information financials financial results stock data stock data current quote charts historical data analyst coverage sec filings sec filings all sec filings annual reports quarterly reports section  filings proxy statements corporate governance corporate governance board of directors board committees governance docs contact the board careers contact for patients science of nerve repair about the nervous system peripheral nerve injuries pni pni map ways to diagnose pni how peripheral nerves repair nerve injuries and treatment options medical glossary resources find a nerve surgeon about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses it’s time to rethink nerve repair™ welcome to axogen nasdaq axgn a leading medical technology company dedicated to peripheral nerve repair axogen introduces click here for details learn about avance nerve graft axogens find a nerve surgeon locator tool click here to find a nerve surgeon jeffrey’s story read this patient story shirleys story read this patient story axogen q  earnings call may   pm et listen to the q  earnings call tollfree at   or listen to the conference call live at axogenincequisolvewebcastcomq webcast th annual roth conference march   listen to a replay of the march  roth conference webcast canaccord genuity musculoskeletal conference march   listen to a replay of the march  canaccord conference webcast oppenheimer th annual healthcare conference march   listen to a replay of the march  oppenheimer conference webcast  annual axogen shareholder’s meeting may   pm et renaissance orlando airport hotelorlando fl virtual meeting connecting nerves connecting lives axogen inc seeks to provide surgeons with solutions to repair and protect peripheral nerves as well as provide solutions to measure and monitor nerve function the company has created and licensed a unique combination of patented technologies and has a rich pipeline of new products to change the standard of care for patients with peripheral nerve injuries read about axogen press releases axogen inc discloses terms of recent equity award july   axogen inc to report second quarter  financial results and host conference call on wednesday august   july   news  press resources all news press kit media resources press kit news  events press releases axogen inc discloses terms of recent equity award published by axogen july   axogen inc discloses terms of recent equity award read more press releases axogen inc to report second quarter  financial results and host conference call on wednesday august   published by axogen july   axogen inc to report second quarter  financial results and host conference call on wednesday august   read more press releases axogen inc appoints jon gingrich chief commercial officer published by axogen july   axogen inc appoints jon gingrich chief commercial officer read more avance® nerve graft watch the animation  surgical repair of a peripheral nerve gap with avance® nerve graft axgn price  change undefined  high low volume updated search receive axogen emails sign up to receive updates and news from axogen first name last name email address yelp yelp sorry you’re not allowed to access this page contact yelp if you keep experiencing issues bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one